Blow For Janssen As England's NICE Rejects Depression Spray Spravato
Draft Guidance Out For Consultation Until 18 February
Uncertainties over clinical and cost effectiveness are behind the health technology assessment body’s recommendation against Spravato's use on the National Health Service.
